CorMedix Inc. is upgraded to Hold due to near-term momentum is positive, but long-term risk-reward remains challenging. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback